Cargando…
BAP1 as a guardian of genome stability: implications in human cancer
BAP1 is a ubiquitin C-terminal hydrolase domain-containing deubiquitinase with a wide array of biological activities. Studies in which advanced sequencing technologies were used have uncovered a link between BAP1 and human cancer. Somatic and germline mutations of the BAP1 gene have been identified...
Autores principales: | Kwon, Jongbum, Lee, Daye, Lee, Shin-Ai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167335/ https://www.ncbi.nlm.nih.gov/pubmed/37009801 http://dx.doi.org/10.1038/s12276-023-00979-1 |
Ejemplares similares
-
Targeting BAP1 with small compound inhibitor for colon cancer treatment
por: Kang, Minhwa, et al.
Publicado: (2023) -
CHIP and BAP1 Act in Concert to Regulate INO80 Ubiquitination and Stability for DNA Replication
por: Seo, Hye-Ran, et al.
Publicado: (2021) -
Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
por: Park, Seul Gi, et al.
Publicado: (2020) -
BAP1 in cancer: epigenetic stability and genome integrity
por: Caporali, Sabrina, et al.
Publicado: (2022) -
BAP1: role in carcinogenesis and clinical implications
por: Kobrinski, Daniel A., et al.
Publicado: (2020)